Status:
RECRUITING
Prospective Study on Clinical Outcomes of Spontaneous Pneumothorax
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Pneumothorax, Spontaneous
Eligibility:
All Genders
18+ years
Brief Summary
Pneumothorax can be fatal if treatment is delayed or the pneumothorax is refractory. However, the mortality rates and their risk factors were mainly reported from retrospective studies, and local data...
Detailed Description
Pneumothorax is a common respiratory disease and potentially recurrent, especially among patients with pre-existing lung diseases. It frequently requires in-patient care due to the need for invasive t...
Eligibility Criteria
Inclusion
- Inclusion criteria
- All patients with a confirmed diagnosis of spontaneous pneumothorax on admission or during the hospital stay
- Age greater than 18 years old
- Chinese ethnicity
- Able to sign written informed consent to participate in the study
- Exclusion criteria
- Pneumothorax was not found by thoracic imaging
- Traumatic pneumothorax (including iatrogenic pneumothorax)
- Pneumothorax with recent (within one month) lung resection surgery, that may be due to staple line issues
- Trapped lung or non-expandable lungs, without evidence of air leakage
- Patients with psychiatric disease or cognitive impairment that may limit their ability of understanding or giving consent to the study
Exclusion
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
349 Patients enrolled
Trial Details
Trial ID
NCT05397717
Start Date
October 1 2022
End Date
September 30 2026
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong